Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.

Liam S AchesonNadine EzardNicholas LintzerisAdrian DunlopJonathan BrettCraig RodgersAnthony GillMichael ChristmassRebecca McKetinMichael FarrellSteven J ShoptawKrista J Siefried

Published in: PloS one (2022)

This is the first study to assess lisdexamfetamine for the treatment of acute MA withdrawal. If safe and feasible results will go to informing the development of multi-centre randomised controlled trials to determine the efficacy of the intervention.

Keyphrases

liver failure
randomized controlled trial
respiratory failure

clinical trial
study protocol

drug induced
intensive care unit

aortic dissection
combination therapy